+1.3105020770

662 Encinitas Blvd. Suite 248, Encinitas, CA 92024

AvenzoarPharma

Avenzoar Pharmaceuticals, Inc. is seeking to leverage its growth strategy by acquiring or licensing new therapeutics, in addition to developing its new products.

Partnering is a fundamental part of Avenzoar Pharmaceuticals' business strategy. We are seeking to expand our offerings by adding appropriate development programs into our pipeline. Our management team has a wealth of experience in a variety of partnership settings. We are currently interested in the following types of collaborations: In-licensing new product candidates, accessing value-added API, and manufacturing and distribution services.

If you are interested in discussing partnership or business development opportunities, please contact us at: 
spandol@avenzoarpharma.com          Tel: 1.310-502-0770

PARTNERSHIP

The following organizations have meaningfully contributed to the discovery and pre-clinical development work for AP-001 and several other potential compounds:




The Hirshberg Foundation






The Cedars-Sinai Medical Center







The National Institute of Health

+1.3105020770

662 Encinitas Blvd. Suite 248, Encinitas, CA 92024